Somatic mutation variant analysis in rural, resectable non‐small cell lung carcinoma patients

Keyphrases

• Somatic mutation 100%
• Non-small Cell Lung Cancer (NSCLC) 100%
• Non-small Cell Lung Cancer Patients 100%
• Variation Analysis 100%
• Mutation Type 100%
• Whole Exome Sequencing 60%
• Tumor mutational Burden 60%
• Somatic Variants 40%
• Tumor Protein p53 (TP53) 40%
• Rural Patients 40%
• Mutant Frequency 40%
• CBioPortal 40%
• Tumor 20%
• Non-associated 20%
• Resection 20%
• Patient Outcomes 20%
• Targeted Therapy 20%
• Normal Pair 20%
• Mutational Status 20%
• Surgical Resection 20%
• Tumor Stage 20%
• Variant Calling 20%
• Access to Care 20%
• Tumor Survival 20%
• Lack of Access 20%
• Gene-based 20%
• Uncommon mutation 20%
• Resectable Lung Cancer 20%
• Specific Difference 20%
• Non-synonymous mutation 20%
• Actionable Genes 20%
• Actionable Target 20%
• Adjuvant Trials 20%

Biochemistry, Genetics and Molecular Biology

• Somatic Mutation 100%
• Exome Sequencing 100%
• Cancer Staging 33%
• Targeted Therapy 33%